BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25628467)

  • 1. Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.
    Green DJ; Shadman M; Jones JC; Frayo SL; Kenoyer AL; Hylarides MD; Hamlin DK; Wilbur DS; Balkan ER; Lin Y; Miller BW; Frost SH; Gopal AK; Orozco JJ; Gooley TA; Laird KL; Till BG; Bäck T; Sandmaier BM; Pagel JM; Press OW
    Blood; 2015 Mar; 125(13):2111-9. PubMed ID: 25628467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model.
    O'Steen S; Comstock ML; Orozco JJ; Hamlin DK; Wilbur DS; Jones JC; Kenoyer A; Nartea ME; Lin Y; Miller BW; Gooley TA; Tuazon SA; Till BG; Gopal AK; Sandmaier BM; Press OW; Green DJ
    Blood; 2019 Oct; 134(15):1247-1256. PubMed ID: 31395601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Laszlo GS; Sandmaier BM; Kehret AR; Orozco JJ; Hamlin DK; Dexter SL; Lim SYT; Cole FM; Huo J; Wilbur DS; Walter RB
    Leuk Lymphoma; 2023; 64(7):1335-1339. PubMed ID: 37170642
    [No Abstract]   [Full Text] [Related]  

  • 4. New approaches for imaging and therapy of solid cancer.
    Sollini M; Boni R; Traino AC; Lazzeri E; Pasqualetti F; Modeo L; Mariani G; Petrini M; Erba PA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):168-83. PubMed ID: 25693421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow up of rates of secondary malignancy and late relapse of two trials using radioimmunotherapy consolidation following induction chemotherapy for previously untreated indolent lymphoma.
    Reiss J; Link B; Ruan J; Furman R; Coleman M; Leonard J; Martin P
    Leuk Lymphoma; 2015; 56(10):2870-5. PubMed ID: 25676037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
    Muylle K; Flamen P; Vugts DJ; Guiot T; Ghanem G; Meuleman N; Bourgeois P; Vanderlinden B; van Dongen GA; Everaert H; Vaes M; Bron D
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1304-14. PubMed ID: 25792453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models.
    Frost SH; Frayo SL; Miller BW; Orozco JJ; Booth GC; Hylarides MD; Lin Y; Green DJ; Gopal AK; Pagel JM; Bäck TA; Fisher DR; Press OW
    PLoS One; 2015; 10(3):e0120561. PubMed ID: 25785845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches.
    Podczervinski S; Stednick Z; Helbert L; Davies J; Jagels B; Gooley T; Casper C; Pergam SA
    Am J Infect Control; 2015 Mar; 43(3):228-33. PubMed ID: 25728148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.
    Gori JL; Butler JM; Chan YY; Chandrasekaran D; Poulos MG; Ginsberg M; Nolan DJ; Elemento O; Wood BL; Adair JE; Rafii S; Kiem HP
    J Clin Invest; 2015 Mar; 125(3):1243-54. PubMed ID: 25664855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
    Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
    J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthracyclines induce double-strand DNA breaks at active gene promoters.
    Yang F; Kemp CJ; Henikoff S
    Mutat Res; 2015 Mar; 773():9-15. PubMed ID: 25705119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals.
    Pruszyński M; Łyczko M; Bilewicz A; Zalutsky MR
    Nucl Med Biol; 2015 May; 42(5):439-445. PubMed ID: 25687450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Hypertension and Associated Risk Factors in Western Alaska Native People: The Western Alaska Tribal Collaborative for Health (WATCH) Study.
    Jolly SE; Koller KR; Metzger JS; Day GM; Silverman A; Hopkins SE; Austin MA; Boden-Albala B; Ebbesson SO; Boyer BB; Howard BV; Umans JG
    J Clin Hypertens (Greenwich); 2015 Oct; 17(10):812-8. PubMed ID: 25644577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue.
    Rachinger W; Stoecklein VM; Terpolilli NA; Haug AR; Ertl L; Pöschl J; Schüller U; Schichor C; Thon N; Tonn JC
    J Nucl Med; 2015 Mar; 56(3):347-53. PubMed ID: 25635133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin's lymphoma.
    Goto H; Shiraishi Y; Okada S
    Explor Target Antitumor Ther; 2024; 5(1):208-224. PubMed ID: 38464386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models.
    Metebi A; Kauffman N; Xu L; Singh SK; Nayback C; Fan J; Johnson N; Diemer J; Grimm T; Zamiara M; Zinn KR
    Front Chem; 2023; 11():1322773. PubMed ID: 38333550
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors.
    Orozco JJ; Vo PT; Gooley TA; Haaf RL; Lundberg SJ; Hamlin DK; Wilbur DS; Matesan MC; Fisher DR; Gopal AK; Green DJ; Pagel JM; Sandmaier BM
    Clin Cancer Res; 2024 Jan; 30(2):274-282. PubMed ID: 37939122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cure of Disseminated Human Lymphoma with [
    Longtine MS; Shim K; Hoegger MJ; Benabdallah N; Abou DS; Thorek DLJ; Wahl RL
    J Nucl Med; 2023 Jun; 64(6):924-931. PubMed ID: 37024304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astatine-211 based radionuclide therapy: Current clinical trial landscape.
    Albertsson P; Bäck T; Bergmark K; Hallqvist A; Johansson M; Aneheim E; Lindegren S; Timperanza C; Smerud K; Palm S
    Front Med (Lausanne); 2022; 9():1076210. PubMed ID: 36687417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure of Disseminated Human Lymphoma with [
    Shim K; Longtine MS; Abou DS; Hoegger MJ; Laforest RS; Thorek DLJ; Wahl RL
    J Nucl Med; 2023 Apr; 64(4):542-548. PubMed ID: 36357179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.